Cargando…
Cholangiocarcinoma Disease Modelling Through Patients Derived Organoids
Cancer organoids are 3D phenotypic cultures that can be established from resected or biopsy tumour samples and can be grown as mini tumours in the dish. Flourishing evidence supports the feasibility of patient derived organoids (PDO) from a number of solid tumours. Evidence for cholangiocarcinoma (C...
Autores principales: | Amato, Francesco, Rae, Colin, Prete, Maria Giuseppina, Braconi, Chiara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226733/ https://www.ncbi.nlm.nih.gov/pubmed/32235647 http://dx.doi.org/10.3390/cells9040832 |
Ejemplares similares
-
Patient-Derived Organoids as a Model for Cancer Drug Discovery
por: Rae, Colin, et al.
Publicado: (2021) -
Heterogeneity of Cholangiocarcinoma Immune Biology
por: Vita, Francesca, et al.
Publicado: (2023) -
Patient-Derived Organoids of Cholangiocarcinoma
por: Maier, Christopher Fabian, et al.
Publicado: (2021) -
Emerging molecular targets and therapy for cholangiocarcinoma
por: Kayhanian, Hamzeh, et al.
Publicado: (2017) -
Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells
por: Zhou, Guoying, et al.
Publicado: (2022)